Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARTAN: Transmission of Artemisinin Resistant Parasites Before and After ACT
NCT06347471Phase 4Completed
- Sponsor
- Infectious Diseases Research Collaboration
- Start
- May 2024
- Primary completion
- Nov 2025
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine, dihydroartemisinin + piperaquine in Malaria, sponsored by Infectious Diseases Research Collaboration. Started May 2024; status: completed.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT06347471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06347471.